Resultados de procura - David T. Teachey

Limitar resultados
  1. 1
    Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS)

    Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS) por David T. Teachey

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome

    New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome por David T. Teachey

    Publicado 2011
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Predicting relapse risk in childhood acute lymphoblastic leukaemia

    Predicting relapse risk in childhood acute lymphoblastic leukaemia por David T. Teachey, Stephen P. Hunger

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Diagnosis and Management of Autoimmune Cytopenias in Childhood

    Diagnosis and Management of Autoimmune Cytopenias in Childhood por David T. Teachey, Michele P. Lambert

    Publicado 2013
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  5. 5
    T-cell acute lymphoblastic leukemia

    T-cell acute lymphoblastic leukemia por Elizabeth A. Raetz, David T. Teachey

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  6. 6
    Autoimmune lymphoproliferative syndrome: more than a FAScinating disease

    Autoimmune lymphoproliferative syndrome: more than a FAScinating disease por Karen L. Bride, David T. Teachey

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Pré-impressão
    Engadir a favoritos
    Gardado en:
  7. 7
    Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia

    Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia por David T. Teachey, Ching‐Hon Pui

    Publicado 2019
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  8. 8
    How I treat newly diagnosed T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in children

    How I treat newly diagnosed T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in children por David T. Teachey, David O’Connor

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome

    Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome por Chelsea Kotch, David M. Barrett, David T. Teachey

    Publicado 2019
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  10. 10
    Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy

    Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy por Andrew D. Hughes, David T. Teachey, Caroline Diorio

    Publicado 2024
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  11. 11
    Toxicity management for patients receiving novel T-cell engaging therapies

    Toxicity management for patients receiving novel T-cell engaging therapies por David M. Barrett, David T. Teachey, Stephan A. Grupp

    Publicado 2013
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  12. 12
    Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)

    Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS) por David T. Teachey, Alix E. Seif, Stephan A. Grupp

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  13. 13
    Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies

    Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies por David T. Teachey, Stephan A. Grupp, Valerie I. Brown

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  14. 14
    Targeting the PI3K/mTOR Pathway in Pediatric Hematologic Malignancies

    Targeting the PI3K/mTOR Pathway in Pediatric Hematologic Malignancies por Sarah K. Tasian, David T. Teachey, Susan R. Rheingold

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  15. 15
    Cellular therapy: Immune‐related complications

    Cellular therapy: Immune‐related complications por Joseph H. Oved, David M. Barrett, David T. Teachey

    Publicado 2019
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  16. 16
    Optimizing therapy in the modern age: differences in length of maintenance therapy in acute lymphoblastic leukemia

    Optimizing therapy in the modern age: differences in length of maintenance therapy in acute lymphoblastic leukemia por David T. Teachey, Stephen P. Hunger, Mignon L. Loh

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies

    Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies por David Barrett, Valerie I. Brown, Stephan A. Grupp, David T. Teachey

    Publicado 2012
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  18. 18
    CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia

    CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia por Shannon L. Maude, David T. Teachey, David L. Porter, Stephan A. Grupp

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  19. 19
    Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies

    Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies por Shannon L. Maude, David M. Barrett, David T. Teachey, Stephan A. Grupp

    Publicado 2014
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  20. 20
    Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'

    Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL' por David T. Teachey, Michael R. Bishop, David G. Maloney, Stephan A. Grupp

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: